ORTIN GLOBAL (ORTINGLOBE)₹13.98−0.92%Pharmaceuticals
In the Mar 2026 quarter (standalone), ORTIN GLOBAL reported sales of ₹0.29 Cr, up 262.5% from Mar 2025, and net profit of ₹0 Cr. For the year to Mar 2026, sales were ₹0.40 Cr and net profit −₹0.73 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.56 | 0.26 | 0.13 | 0.29 | 0.20 | 0.04 | 0.02 | 0.08 | 0.07 | 0.00 | 0.00 | 0.29 |
| Expenses | 1.38 | 1.16 | 2.73 | 3.34 | 0.30 | 0.49 | 0.15 | 0.24 | 0.23 | 0.50 | 0.05 | 0.30 |
| Operating Profit | 0.17 | −0.89 | −2.59 | −3.04 | −0.09 | −0.44 | −0.12 | −0.15 | −0.15 | −0.49 | −0.04 | 0.00 |
| OPM % | 11.6% | −333.3% | −1,857.1% | −1,016.6% | −47.5% | −899.9% | −433.3% | −177.7% | −199.9% | −4,999.9% | −499.9% | −3.3% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.10 | 0.14 | 0.13 | 0.07 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.07 | 0.07 | 0.07 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | −1.10 | −2.79 | −3.17 | −0.09 | −0.46 | −0.09 | −0.15 | −0.15 | −0.49 | −0.04 | 0.00 |
| Tax % | 0.0% | 1.8% | −0.7% | 30.2% | 0.0% | 0.0% | 10.0% | 0.0% | 6.2% | 0.0% | 0.0% | 0.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.01 | −1.11 | −2.78 | −4.13 | −0.09 | −0.46 | −0.10 | −0.15 | −0.17 | −0.49 | −0.04 | 0.00 |
| EPS (Rs) | 0.03 | −1.39 | −3.42 | −5.08 | −0.11 | −0.59 | −0.13 | −0.21 | −0.23 | −0.62 | −0.05 | −0.02 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 62.64 | 61.56 | 79.59 | 167 | 197 | 8.15 | 8.22 | 5.99 | 2.00 | 0.33 | 0.40 | 0.36 |
| Expenses | 56.73 | 56.01 | 74.09 | 160 | 191 | 6.90 | 7.84 | 5.46 | 6.39 | 1.22 | 1.12 | 1.08 |
| Operating Profit | 5.88 | 5.44 | 5.39 | 6.66 | 5.68 | 1.23 | 0.37 | 0.52 | −4.38 | −0.88 | −0.71 | −0.68 |
| OPM % | 9.5% | 8.9% | 6.8% | 4.0% | 2.9% | 15.3% | 4.6% | 8.9% | −218.3% | −261.7% | −175.5% | −188.9% |
| Other Income | 0.56 | 0.31 | 0.44 | 0.12 | 0.17 | 0.04 | 0.18 | 0.00 | −1.97 | 0.05 | 0.00 | 0.00 |
| Interest | 3.41 | 2.93 | 3.48 | 3.21 | 3.20 | 0.86 | 0.80 | 0.39 | 0.47 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.66 | 1.71 | 1.68 | 1.76 | 1.97 | 0.30 | 0.30 | 0.24 | 0.24 | 0.02 | 0.00 | 0.00 |
| Profit before tax | 1.38 | 1.12 | 0.67 | 1.83 | 0.70 | 0.12 | −0.52 | −0.10 | −7.07 | −0.83 | −0.71 | −0.68 |
| Tax % | 41.0% | 55.7% | 0.0% | 30.4% | 181.7% | −623.1% | −24.5% | −18.2% | 13.5% | 1.2% | 2.8% | — |
| Exceptional items | 0.03 | 0.02 | 0.14 | 0.00 | −0.02 | 0.00 | 0.00 | −0.03 | −1.77 | 0.03 | 0.00 | 0.00 |
| Net Profit | 0.82 | 0.49 | 0.67 | 1.27 | −0.55 | 0.94 | −0.39 | −0.08 | −8.02 | −0.84 | −0.73 | −0.70 |
| EPS (Rs) | 0.50 | 0.31 | 0.41 | 0.77 | −0.34 | 1.18 | −0.50 | −0.12 | −9.88 | −1.06 | −0.92 | −0.92 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16.97 | 16.99 | 16.99 | 16.99 | 16.97 | 16.98 | 8.14 | 8.15 | 8.15 | 8.15 | 8.14 | 8.13 |
| Reserves | 5.48 | 6.30 | 6.44 | 7.12 | 8.11 | 6.85 | 3.21 | 2.82 | 2.72 | −5.30 | −6.15 | −6.88 |
| Borrowings | 20.98 | 20.88 | 17.35 | 17.36 | 19.48 | 19.60 | 6.94 | 6.15 | 6.46 | 1.81 | 0.26 | 1.01 |
| Other Liabilities | 23.96 | 21.24 | 20.85 | 32.31 | 60.72 | 73.31 | 2.96 | 3.60 | 3.88 | 2.04 | 1.54 | 2.39 |
| Total Liabilities | 67.39 | 65.41 | 61.63 | 73.78 | 105 | 117 | 21.25 | 20.72 | 21.21 | 6.70 | 3.79 | 4.65 |
| Fixed Assets | 21.85 | 21.64 | 20.70 | 20.04 | 21.30 | 22.44 | 14.37 | 14.22 | 13.97 | 0.02 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.34 | 0.39 | 0.52 | 0.42 | 0.42 | 0.42 | 0.42 | 0.00 | 0.00 | 0.00 |
| Investments | 0.02 | 0.02 | 0.06 | 0.07 | 0.07 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 45.52 | 43.75 | 40.53 | 53.28 | 83.39 | 93.82 | 6.46 | 6.08 | 6.82 | 6.68 | 3.79 | 4.65 |
| Inventories | 21.93 | 16.81 | 17.63 | 23.97 | 36.90 | 49.85 | 1.82 | 1.73 | 2.59 | 0.04 | 0.01 | 0.00 |
| Trade receivables | 17.11 | 9.12 | 15.22 | 21.83 | 37.77 | 37.11 | 3.90 | 3.23 | 3.41 | 1.76 | 0.25 | 0.19 |
| Cash & equivalents | 1.75 | 1.67 | 1.44 | 1.70 | 2.15 | 2.51 | 0.19 | 0.61 | 0.27 | 2.35 | 0.38 | 0.62 |
| Total Assets | 67.39 | 65.41 | 61.63 | 73.78 | 105 | 117 | 21.25 | 20.72 | 21.21 | 6.70 | 3.79 | 4.65 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −1.39 | 0.53 | 1.95 | 1.57 | 6.55 | 3.31 | 18.09 | 2.16 | −0.26 | −4.81 | −0.42 | −0.57 |
| Cash from investing activity | 0.21 | −0.85 | −1.25 | −0.89 | −3.26 | −3.08 | 0.06 | −0.12 | 0.00 | 11.96 | 0.00 | 0.03 |
| Cash from financing activity | 1.72 | 0.26 | −0.81 | 0.06 | −2.88 | −1.32 | −9.84 | −0.47 | 0.89 | −3.48 | 0.32 | 0.74 |
| Net cash flow | 0.57 | −0.06 | −0.13 | 0.72 | 0.36 | −1.11 | 8.22 | 1.54 | 0.65 | 3.71 | −0.08 | 0.22 |
| Capex | 0.00 | 1.43 | 0.77 | 1.18 | 3.00 | 3.11 | 0.00 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free cash flow | −1.37 | −0.91 | 0.82 | 0.76 | 3.37 | 0.27 | 18.02 | 2.01 | −0.23 | 7.20 | −0.40 | −0.51 |
| CFO / OP % | −14.0% | 17.0% | 47.0% | 40.0% | 104.0% | 72.0% | 1,454.0% | 566.0% | −47.0% | 80.0% | 46.0% | 78.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 104 | 53 | 90 | 100 | 82 | 69 | 175 | 144 | 208 | 321 | 279 | 178 |
| Inventory days | 192 | 149 | 158 | 152 | 100 | 118 | 169 | 136 | 280 | 5 | 35 | 0 |
| Days payable | 152 | 26 | 109 | 144 | 146 | 157 | 125 | 63 | 168 | 9 | 71 | — |
| Cash conversion cycle | 144 | 176 | 139 | 108 | 36 | 30 | 219 | 217 | 320 | 317 | 243 | 177 |
| Working capital days | 30 | 17 | 38 | 42 | 18 | 12 | −86 | −108 | −42 | 359 | 1,525 | 731 |
| ROCE % | 12.1% | 11.0% | 9.6% | 9.5% | 11.8% | 9.0% | 3.3% | 1.6% | 1.8% | −40.6% | −25.1% | −32.1% |
For the Mar 2026 quarter, ORTIN GLOBAL reported sales of ₹0.29 Cr, up 262.5% year on year and net profit of ₹0 Cr. The operating margin was −3.3%.
ORTIN GLOBAL's sales for the year to Mar 2026 were ₹0.40 Cr; over the last twelve months they were ₹0.36 Cr.
Net profit for the year to Mar 2026 was −₹0.73 Cr, and −₹0.70 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.92.
ORTIN GLOBAL reported borrowings of ₹1.01 Cr at Mar 2026, against cash and equivalents of ₹0.62 Cr.
Cash from operations was −₹0.57 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.51 Cr.